COVID-19-Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine.

Oh, Joan; Amber-Monta, Katrina; Sahota, Puneet Chawla; Pradhan, Basant K; Koola, Maju Mathew

Oh, Joan; Amber-Monta, Katrina; Sahota, Puneet Chawla; Pradhan, Basant K; Koola, Maju Mathew.

Oh J; Cooper Medical School of Rowan University, Camden, New Jersey.
Amber-Monta K; Department of Psychiatry, Lehigh Valley Health Network, Allentown, Pennsylvania.
Sahota PC; Department of Psychiatry and Behavioral Health, Cooper University Health Care, Camden, New Jersey.
Pradhan BK; Department of Psychiatry and Behavioral Health, Cooper University Health Care, Camden, New Jersey.
Koola MM; Department of Psychiatry and Behavioral Health, Cooper University Health Care, Camden, New Jersey.

Prim Care Companion CNS Disord ; 24(6)2022 11 17.

Article in English | MEDLINE | ID: covidwho-2233938

Subject(s)

COVID-19; Catatonia; Electroconvulsive Therapy; Humans; Catatonia/drug therapy; Benzodiazepines; Amantadine/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Catatonia / Electroconvulsive Therapy / COVID-19 Limits: Humans Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google